Literature DB >> 20629130

Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.

Tobias Warnecke1, Stephan Oelenberg, Inga Teismann, Christina Hamacher, Hubertus Lohmann, Erich Bernd Ringelstein, Rainer Dziewas.   

Abstract

Dysphagia is a frequent and early symptom in progressive supranuclear palsy (PSP) predisposing patients to aspiration pneumonia. Fiberoptic endoscopic evaluation of swallowing (FEES) has emerged as a valuable apparative tool for objective evaluation of neurogenic dysphagia. This is the first study using FEES to investigate the nature of swallowing impairment in PSP. Eighteen consecutive PSP patients (mean age 69.7 +/- 9.0 years) were included. The salient findings of FEES in PSP patients were compared with those of 15 patients with Parkinson's disease (PD). In 7 PSP patients, a standardized FEES protocol was performed to explore levodopa (L-dopa) responsiveness of dysphagia. Most frequent abnormalities detected by FEES were bolus leakage, delayed swallowing reflex, and residues in valleculae and piriformes. Aspiration events with at least one food consistency occurred in nearly 30% of PSP patients. Significant pharyngeal saliva pooling was observed in 4 PSP patients. We found no difference of salient endoscopic findings between PSP and PD patients. Endoscopic dysphagia severity in PSP correlated positively with disease duration, clinical disability, and cognitive impairment. No correlation was found with dysarthria severity. In early PSP patients, swallowing dysfunction was solely characterized by liquid leakage with the risk of predeglutitive aspiration during the oral phase of swallowing. Two PSP patients showed relevant improvement of swallowing function after L-dopa challenge. Chin tuck-maneuver, hard swallow, and modification of food consistency were identified as the most effective therapeutic interventions. In conclusion, FEES assessment can deliver important findings for the diagnosis and refined therapy of dysphagia in PSP patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20629130     DOI: 10.1002/mds.23060

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

1.  [FEES for neurogenic dysphagia: training curriculum of the German Society of Neurology and the German Stroke Society].

Authors:  R Dziewas; J Glahn; C Helfer; G Ickenstein; J Keller; S Lapa; C Ledl; B Lindner-Pfleghar; D Nabavi; M Prosiegel; A Riecker; S Stanschus; T Warnecke; O Busse
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

Review 2.  History of Fiberoptic Endoscopic Evaluation of Swallowing for Evaluation and Management of Pharyngeal Dysphagia: Changes over the Years.

Authors:  Susan E Langmore
Journal:  Dysphagia       Date:  2017-01-18       Impact factor: 3.438

3.  Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy.

Authors:  Sara Varanese; Paolo Di Ruscio; Leila Ben M' Barek; Astrid Thomas; Marco Onofrj
Journal:  J Neurol       Date:  2014-01-12       Impact factor: 4.849

4.  Dysphagia in patients with acute striatocapsular hemorrhage.

Authors:  Sonja Suntrup; Tobias Warnecke; Andre Kemmling; Inga Kristina Teismann; Christina Hamacher; Stefan Oelenberg; Rainer Dziewas
Journal:  J Neurol       Date:  2011-06-07       Impact factor: 4.849

Review 5.  Oropharyngeal dysphagia: manifestations and diagnosis.

Authors:  Nathalie Rommel; Shaheen Hamdy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

Review 6.  Dysphagia in Parkinson's Disease.

Authors:  Inga Suttrup; Tobias Warnecke
Journal:  Dysphagia       Date:  2015-11-21       Impact factor: 3.438

7.  Dysphagia in Progressive Supranuclear Palsy.

Authors:  Heather M Clark; Julie A G Stierwalt; Nirubol Tosakulwong; Hugo Botha; Farwa Ali; Jennifer L Whitwell; Keith A Josephs
Journal:  Dysphagia       Date:  2019-11-01       Impact factor: 3.438

8.  Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy.

Authors:  Heather M Clark; Nirubol Tosakulwong; Stephen D Weigand; Farwa Ali; Hugo Botha; Nha Trang Thu Pham; Christopher G Schwarz; Robert I Reid; Matthew L Senjem; Clifford R Jack; Val J Lowe; J Eric Ahlskog; Keith A Josephs; Jennifer L Whitwell
Journal:  Mov Disord       Date:  2021-08-23       Impact factor: 10.338

9.  Subtle Esophageal Motility Alterations in Parkinsonian Syndromes: Synucleinopathies vs. Tauopathies.

Authors:  Inga Claus; Judith Suttrup; Paul Muhle; Sonja Suntrup-Krueger; Marie-Luise Siemer; Frank Lenze; Rainer Dziewas; Tobias Warnecke
Journal:  Mov Disord Clin Pract       Date:  2018-05-15

Review 10.  Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Authors:  Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.